Cancer News and Research

Latest Cancer News and Research

Iowa proposal to block Planned Parenthood funding dies; Ariz. Gov. signs bill allowing employers to opt out of covering contraception

Iowa lawmakers are the latest to consider defunding Planned Parenthood over the organization's performance of abortions, though the proposal died on the last day of the legislative session. Elsewhere, Arizona Gov. Jan Brewer signs a bill allowing employers to opt out of covering contraception in their insurance plans.

15 May 2012

Women more likely to have different set of sports injuries than men

With the predominance of male athletes featured on television and covered in the media year-round, most Americans are familiar with some of the most common injuries sustained by men in various sports. As the 2012 Summer Games approaches, female athletes will have additional opportunities to be featured, but are their potential injury risks the same as their male counterparts?

15 May 2012

Cubist announces results from CB-5945 Phase 2 studies on chronic non-cancer pain, OIC

Cubist Pharmaceuticals, Inc. today announced that the results from the Phase 2 studies of CB-5945 (formerly ADL5945) in patients with chronic non-cancer pain and opioid-induced constipation (OIC) will be presented at the 31st Annual Scientific Meeting of the American Pain Society taking place May 16 to 19, 2012, in Honolulu and during Digestive Disease Week 2012 taking place May 19 to 22, 2012, in San Diego.

15 May 2012

Researchers identify new biomarker and therapeutic target for pancreatic cancer

Researchers at the University of California, San Diego School of Medicine and Moores Cancer Center have identified a new biomarker and therapeutic target for pancreatic cancer, an often-fatal disease for which there is currently no reliable method for early detection or therapeutic intervention. The paper will be published May 15 in Cancer Research.

15 May 2012

Latest statistics: Cancer deaths in 50-59 year olds have dropped to 14,000

The number of people in their 50s dying prematurely from cancer in the UK has fallen below 14,000 for the first time in 40 years according to new Cancer Research UK figures published today.

15 May 2012

BioAlliance Pharma commences Livatag phase III trial in hepatocellular carcinoma

BioAlliance Pharma SA, a Company dedicated to orphan oncology products and specialty products, today announces the initiation of ReLive, its phase III clinical trial with Livatag(doxorubicin Transdrug), as scheduled in the advancement calendar of the project.

15 May 2012

Lilly to present oncology data from more than 25 studies at ASCO annual meeting

Eli Lilly and Company will present data from more than 25 studies at the 48th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, Ill. from June 1 – 5, 2012, including overall survival results from PARAMOUNT, a Phase III study of an ALIMTA (pemetrexed for injection)-based continuation maintenance regimen for the treatment of advanced nonsquamous non-small cell lung cancer.

15 May 2012

MicroRNA-3151 a new independent prognostic marker for acute leukemia

A study has identified microRNA-3151 as a new independent prognostic marker in certain patients with acute leukemia. The study involves patients with acute myeloid leukemia and normal-looking chromosomes.

15 May 2012

HyStem-C effective in transplantation of heart muscle-derived cells for heart disease

BioTime, Inc. announced today the publication of a scientific paper demonstrating the effectiveness of HyStem-C in the transplantation of heart muscle-derived cells in an animal model of heart disease.

14 May 2012

GOP's Medicare plan has some candidates playing defense

The budget plan advanced by Rep. Paul Ryan, R-Wis., has become a hot topic in many congressional races. One example is the Illinois race between Rep. Joe Walsh, a Republican, and Democratic challenger and Iraqi war veteran Tammy Duckworth.

14 May 2012

Breast brachytherapy with strut-based applicator effective for early-stage breast cancer

Breast brachytherapy with a strut-based applicator is a well-tolerated and effective treatment for early-stage breast cancer, according to a multi-site study with a median follow-up of four years. The research was presented as a scientific poster at the European Society for Radiology & Oncology (ESTRO) World Congress of Brachytherapy in Barcelona, May 10-12.

14 May 2012

U-Systems somo•v Automated Breast Ultrasound system granted FDA PMA approvable letter

U-Systems, the leader in automated breast ultrasound, announced today it has received a PMA approvable letter from the U.S. Food and Drug Administration's (FDA) for the company's somo•v® Automated Breast Ultrasound (ABUS) system.

14 May 2012

Genetic cause of rare genetic disorder, Hamamy syndrome

Scientists at A*STAR's Institute of Medical Biology (IMB), in collaboration with doctors and scientists in Jordan, Turkey, Switzerland and USA, have identified the genetic cause of a birth defect known as Hamamy syndrome .

14 May 2012

New Jefferson Hepatitis C Center

Thomas Jefferson University Hospital recently opened its new Jefferson Hepatitis C Center, one of only a few comprehensive, multidisciplinary centers dedicated to the study of hepatitis C virus and hepatic disease in the Pennsylvania, New Jersey and Delaware tri-state area.

14 May 2012

Important role played by nurse helplines

A survey by Cancer Research UK's helpline nurses has revealed that patients mainly need information to understand their situation and for peace of mind - not just to make treatment choices. The results are published today in Cancer Nursing Practice.

14 May 2012

Soligenix first quarter revenues decrease to $647,418

Soligenix, Inc., a development stage biopharmaceutical company, announced today its financial results for the quarter ending March 31, 2012.

14 May 2012

Biovest plans to file BiovaxID MAA with EMA for treatment of follicular NHL

Biovest International, Inc., a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc., today announced that Biovest plans to file for marketing approval in the European Union (EU) for BiovaxID, its personalized cancer vaccine for the treatment of follicular non-Hodgkin's lymphoma, an incurable cancer of the immune system.

14 May 2012

mTOR protein plays a key role in development of diabetes

The signaling protein mTOR is a key regulator that controls cell growth. Dysfunction of mTOR increases not only the likelihood of developing cancer but also diabetes. In the current issue of the journal Cell Metabolism, Mike Hall and his team from the Biozentrum of the University of Basel describe how inhibition of mTOR signaling can impair carbohydrate metabolism and potentially lead to diabetes.

14 May 2012

Phase II trial to examine effects of resveratrol on individuals with mild to moderate dementia

A national, phase II clinical trial examining the effects of resveratrol on individuals with mild to moderate dementia due to Alzheimer's disease has begun as more than two dozen academic institutions recruit volunteers in the coming months. R. Scott Turner, M.D., Ph.D., director of Georgetown University Medical Center's Memory Disorders Program, is the lead investigator for the national study.

14 May 2012

Analysis stresses importance of multidisciplinary approach to cancer in the elderly

New research showing that almost half of 13,000 patients with head and neck cancers had other health-related problems at the same time is one of the presentations in a special session at the 31st conference of the European Society for Radiotherapy and Oncology (ESTRO 31) today.

14 May 2012

Cancer News and Research

Latest Cancer News and Research

Iowa proposal to block Planned Parenthood funding dies; Ariz. Gov. signs bill allowing employers to opt out of covering contraception

Women more likely to have different set of sports injuries than men

Cubist announces results from CB-5945 Phase 2 studies on chronic non-cancer pain, OIC

Researchers identify new biomarker and therapeutic target for pancreatic cancer

Latest statistics: Cancer deaths in 50-59 year olds have dropped to 14,000

BioAlliance Pharma commences Livatag phase III trial in hepatocellular carcinoma

Lilly to present oncology data from more than 25 studies at ASCO annual meeting

MicroRNA-3151 a new independent prognostic marker for acute leukemia

HyStem-C effective in transplantation of heart muscle-derived cells for heart disease

GOP's Medicare plan has some candidates playing defense

Breast brachytherapy with strut-based applicator effective for early-stage breast cancer

U-Systems somo•v Automated Breast Ultrasound system granted FDA PMA approvable letter

Genetic cause of rare genetic disorder, Hamamy syndrome

New Jefferson Hepatitis C Center

Important role played by nurse helplines

Soligenix first quarter revenues decrease to $647,418

Biovest plans to file BiovaxID MAA with EMA for treatment of follicular NHL

mTOR protein plays a key role in development of diabetes

Phase II trial to examine effects of resveratrol on individuals with mild to moderate dementia

Analysis stresses importance of multidisciplinary approach to cancer in the elderly

Industry Focus eBook - Oncology (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in